Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

Jørgensen, Anders Berg, Frikke-Schmidt, Ruth, Nordestgaard, Børge G., Tybjærg-Hansen, Anne·2014·New England Journal of Medicine

DOI 10.1056/nejmoa1308027

Cited by (923)

Items 501–600 of 923

Depletion of loss-of-function germline mutations in centenarians reveals longevity genes
Kejun Ying, José Pedro Castro, Anastasia V. Shindyapina, Alexander Tyshkovskiy, Mahdi Moqri, Ludger J.E. Goeminne, Sofiya Milman, Zhengdong D. Zhang, Nir Barzilai, Vadim N. Gladyshev · 2024 · Nature Communications
Human Genetics of Atherothrombotic Disease and its Risk Factors
Daniel James Rader · 2015 · Arteriosclerosis Thrombosis and Vascular Biology
A genome-wide study of lipid response to fenofibrate in Caucasians
Marguerite R. Irvin, Daniel Miller Rotroff, Stella W. Aslibekyan, Degui Zhi, Bertha Hidalgo, Alison A. Motsinger‐Reif, Skylar W. Marvel, Vinodh Srinivasasainagendra, Steven A. Claas, John B. Buse et al. · 2016 · Pharmacogenetics and Genomics
Identification of Shared and Unique Serum Lipid Profiles in Diabetes Mellitus and Myocardial Infarction
Sanela Kjellqvist, Christian D. Klose, Michał A. Surma, George Hindy, Inês G. Mollet, Anna Johansson, Patrick Chavaux, Johan Gottfries, Kai Simons, Olle Melander et al. · 2016 · Journal of the American Heart Association
The balance of omega-3 polyunsaturated fatty acids for -reducing residual risks in patients with coronary artery disease
Yuji Nishizaki, Kazunori Shimada, Hiroyuki Daida · 2017 · Acta cardiologica. Supplementum
Triglyceride-lowering trials
ANTHONY C. KEECH, Alicia Josephine Jenkins · 2017 · Current Opinion in Lipidology
ABCA 7 and risk of dementia and vascular disease in the Danish population
Emilie Westerlin Kjeldsen, Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard, Ruth Frikke‐Schmidt · 2017 · Annals of Clinical and Translational Neurology
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)
Azusa Yamazaki, Ryunosuke Ohkawa, Yuka Yamagata, Yuna Horiuchi, Shao-Jui Lai, Takahiro Kameda, Naoya Ichimura, Shuji Tohda, Minoru Tozuka · 2020 · Biological Chemistry
Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects
M. Mar Rodríguez, Pere Rehues, Víctor Iranzo, Jorge Díaz Mora, Clara Balsells, Montse Guardiola, Josep Ribalta · 2021 · Journal of Proteomics
Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease
Kiyoshi Asakura, Yoshiyasu Minami, Daisuke Kinoshita, Masahiro Katamine, Ayami Kato, Aritomo Katsura, Toshimitsu Sato, Yusuke Muramatsu, Takuya Hashimoto, Ryo Kameda et al. · 2021 · International Journal of Cardiology
The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
Laura de Armas‐Rillo, Juan Carlos Quevedo-Abeledo, Vanesa Hernández-Hernández, Antonia de Vera-González, Alejandra González Delgado, José A. García-Dopico, Miguel Ángel González-Gay, Iván Ferraz‐Amaro · 2022 · Arthritis Research & Therapy
Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function
Eduardo Z. Romo, Angela M. Zivkovic · 2022 · Frontiers in Cardiovascular Medicine
Associations between Alcohol Consumption and HDL Subspecies Defined by ApoC3, ApoE and ApoJ: the Cardiovascular Health Study
Trine Levring Wilkens, Helle Sørensen, Majken K. Jensen, Jeremy D. Furtado, Lars Ove Dragsted, Kenneth Jay Mukamal · 2022 · Current Problems in Cardiology
Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia
John J.P. Kastelein, Jonas Hallén, Runar Vige, David A. Fraser, Rong Zhou, Svein Olaf Hustvedt, David G. Orloff, Harold Edward Bays · 2016 · Cardiology
Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice
Yun‐Zi Liu, Xiaoyun Cheng, Ting Zhang, Sojin Lee, Jun Yamauchi, Xiangwei Xiao, George K. Gittes, Shen Qu, Chun‐Lei Jiang, H. Henry Dong · 2016 · Journal of Biological Chemistry
Key differences between apoC-III regulation and expression in intestine and liver
Gabrielle West, Cayla N Rodia, Diana Li, Zania K Johnson, Hongli Dong, Alison B. Kohan · 2017 · Biochemical and Biophysical Research Communications
Evacetrapib and cardiovascular outcomes: reasons for lack of efficacy
Theodosios D. Filippatos, Moses Elisaf · 2017 · Journal of Thoracic Disease
Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association
Kiran Musunuru, Pankaj Kumar Arora, John P. Cooke, Jane F. Ferguson, Ray E. Hershberger, Kathleen T. Hickey, Jin‐Moo Lee, João A.C. Lima, Joseph Loscalzo, Naveen L. Pereira et al. · 2018 · Circulation Genomic and Precision Medicine
Recent developments in pharmacotherapy for hypertriglyceridemia: what’s the current state of the art?
Matilda Florentin, Michael S. Kostapanos, Panagiotis G. Anagnostis, George L. Liamis · 2019 · Expert Opinion on Pharmacotherapy
Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals
Kjeldsen, E. W., Thomassen, J. Q., Rasmussen, K. L., Nordestgaard, B. G., Tybjærg-Hansen, A., Frikke-Schmidt, R. · 2022 · Epidemiology and Psychiatric Sciences
Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and intensity of lipid-lowering therapy in patients with established cardiovascular disease
Pauline C E Schuitema, Frank L.J. Visseren, Børge Grønne Nordestgaard, Martin Teraa, Manon G. van der Meer, Ynte Marije Ruigrok, N. Charlotte Onland‐Moret, Charlotte Koopal · 2025 · Atherosclerosis
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease
Sotirios Tsimikas · 2025 · Current Atherosclerosis Reports
Multiomic Analysis and CRISPR Perturbation Screens Identify Endothelial Cell Programs and Novel Therapeutic Targets for Coronary Artery Disease
Rajat M. Gupta, Gavin R. Schnitzler, Shi Fang, Vivian S. Lee-Kim, Aurelie E. Barry · 2023 · Arteriosclerosis Thrombosis and Vascular Biology
Future Lipid-Altering Therapeutic Options Targeting Residual Cardiovascular Risk
Michel Farnier · 2016 · Current Cardiology Reports
Effects of Torcetrapib and Statin Treatment on ApoC-III and Apoprotein-Defined Lipoprotein Subclasses (from the ILLUMINATE Trial)
John D. Bagdade, Philip J. Barter, Carmen Quiroga, Pierre Alaupovic · 2017 · The American Journal of Cardiology
Integrative analysis of loss-of-function variants in clinical and genomic data reveals novel genes associated with cardiovascular traits
Benjamin Scott Glicksberg, Letizia Amadori, Nicholas K. Akers, Katyayani Sukhavasi, Oscar Franzén, Li Li, Gillian M. Belbin, Kristin L. Akers, Khader Shameer, Marcus A. Badgeley et al. · 2019 · BMC Medical Genomics
Analysis of Rare Variants in Genes Related to Lipid Metabolism in Patients with Familial Hypercholesterolemia in Western Siberia (Russia)
Е. В. Шахтшнейдер, Д. Е. Иванощук, О. В. Тимощенко, Pavel S. Orlov, Sergey Semaev, Emil Valeev, Andrew V. Goonko, Nataliya Ladygina, Mikhail Ivanovich Voevoda · 2021 · Journal of Personalized Medicine
Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
Alejandro Hernández-Camba, Marta Carrillo Palau, Laura Ramos, Laura de Armas‐Rillo, Milagros Vela, Laura Arranz, Miguel Ángel González-Gay, Iván Ferraz‐Amaro · 2022 · Clinical and Translational Gastroenterology
PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk
Pere Rehues, Josefa Girona, Montse Guardiola, Núria Plana, Roberto Scicali, Salvatore Piro, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Lluís Recasens, Marta Pinyol et al. · 2023 · International Journal of Molecular Sciences
Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
Reed Mszar, Sarah Bart, Alexander P. Sakers, Daniel E. Soffer, Dean G. Karalis · 2023 · Journal of Clinical Medicine
Loss-of-function of neuroplasticity-related genes confers risk for human neurodevelopmental disorders
Milo R. Smith, Benjamin Scott Glicksberg, Li Li, Rong Chen, Hirofumi Morishita, Joel T. Dudley · 2017 · Pacific Symposium on Biocomputing (PSB)
Is hypertriglyceridemia atherogenic?
François Roubille, Ariane Sultan, Fabien Huet, Florence Leclercq, Jean‐Christophe Macia, Richard Gervasoni, Delphine Delseny, Mariama Akodad, C. Roubille · 2018 · La Presse Médicale
Human pluripotent stem cells – Unique tools to decipher the effects of environmental and intracellular plastic pollution on human health
Miodrag Stojković, Petra Stojković, Konstantina M. Stanković · 2020 · Environmental Pollution
Association of apolipoprotein-CIII (apoC-III), endothelium-dependent vasodilation and peripheral neuropathy in a multi-ethnic population with type 2 diabetes
Sharon Li Ting Pek, Chee Fang Sum, Lee Ying Yeoh, Simon Biing Ming Lee, Wern Ee Tang, Su Chi Lim, Tavintharan Subramaniam · 2017 · Metabolism
A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening
Sang Jun Lee, Madhupriya Mahankali, Abdallah Bitar, Huafei Zou, Elizabeth Chao, Hung Nguyen, J. González, Dawna Caballero, Mitchell V. Hull, Danling Wang et al. · 2017 · Scientific Reports
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study
Susan R. Davis, Zelalem Nigussie Azene, Andrew Maxwell Tonkin, Robyn L. Woods, John J. McNeil, Rakibul M. Islam · 2024 · Climacteric
Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes
Annemieke Naber, Daniel Demus, Roderick C. Slieker, Simone Nicolardi, Joline W. J. Beulens, Petra J. M. Elders, Aloysius G. Lieverse, Eric J.G. Sijbrands, Leen M. ‘t Hart, Manfred Wuhrer et al. · 2024 · International Journal of Molecular Sciences
Great debate: Plasma triglycerides are an important causal factor and therapeutic target for atherosclerotic cardiovascular disease
Jan Borén, Chris J. Packard, Børge Grønne Nordestgaard, Alberico Luigi Catapano · 2025 · European Heart Journal
Novel Therapeutics for Familial Chylomicronemia Syndrome
Maria Cristina de Oliveira Izar, Francisco Antônio Helfenstein Fonseca · 2025 · Current Atherosclerosis Reports
Evolving targets for lipid‐modifying therapy
Rose Q. Do, Stephen James Nicholls, Gregory G. Schwartz · 2014 · EMBO Molecular Medicine
Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection
Robert S. Rosenson, Wolfgang Köenig · 2016 · Cardiovascular Drugs and Therapy
Comentarios a la guía ESC/EAS 2016 sobre el tratamiento de las dislipemias
Leopoldo Pérez de Isla, LeopoLDo pÉreZ De isLa, Pedro Luis Sánchez Fernández, José Luis Álvarez-Sala, Vivencio Barrios Alonso, Almudena Castro Conde, Enrique Galve Basilio, Luis García‐Ortiz, Pedro Mata López, Eduardo Alegría Ezquerra et al. · 2017 · Revista Española de Cardiología
Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
Thomas Joseph Povsic, Robert C. Scott, Kenneth W. Mahaffey, Robert O. Blaustein, Jay M. Edelberg, Martin P. Lefkowitz, Scott David Solomon, Jonathan C. Fox, Kevin E. Healy, Aarif Yusuf Khakoo et al. · 2017 · Cardiovascular Drugs and Therapy
Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease
George Liu, Pingping Lai, Jiabao Guo, Yu-Hui Wang, X. Xian · 2021 · Medical Review
Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease
Wei Li, Yongyi Wang, Ri‐Tai Huang, Lian Feng, Gen‐Xing Xu, Weijun Wang, Song Xue · 2022 · Molecular Biology Reports
Whole-exome sequencing identifies novel protein-altering variants associated with serum apolipoprotein and lipid concentrations
Niina Sandholm, Ronja Hotakainen, Jani K. Haukka, Fanny Jansson Sigfrids, Emma H. Dahlström, Anni A. Antikainen, Erkka Valo, Anna Syreeni, Elina Kilpeläinen, Anastasia Kytölä et al. · 2022 · Genome Medicine
Using human genetics to predict the effects and side-effects of drugs
Stefan Stender, Anne Tybjærg‐Hansen · 2016 · Current Opinion in Lipidology
Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
Chao Liu, Daniel Gaudet, Yury I. Miller · 2017 · PLoS ONE
The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy
Shigemasa Tani, Ken Nagao, Kenji Kawauchi, Tsukasa Yagi, Wataru Atsumi, Rei Matsuo, Atsushi Hirayama · 2017 · American Journal of Cardiovascular Drugs
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study
Julian C. van Capelleveen, Sang Rok Lee, Rutger Verbeek, John J.P. Kastelein, Nicholas J. Wareham, Erik S.G. Stroes, G. Kees Hovingh, Kay‐Tee Khaw, S. Matthijs Boekholdt, Joseph Lee Witztum et al. · 2018 · Journal of clinical lipidology
Genetics and regulation of HDL metabolism
Dimitris Kardassis, Efstathia Thymiakou, Angeliki Chroni · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Genetic insights into statin-associated diabetes risk
Daniel I. Swerdlow, David Preiss · 2016 · Current Opinion in Lipidology
Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
Fabiana Hanna Rached, Marcio Hiroshi Miname, Viviane Zorzanelli Rocha, André Zimerman, Fernando Yue Cesena, Andrei Carvalho Sposito, Raul Dias Santos, Paulo Eduardo Ballvé Behr, Henrique Tria Bianco, Renato Jorge Alves et al. · 2025 · Arquivos Brasileiros de Cardiologia
Genetic analysis of DNA methylation in dyslipidemia: a case-control study
Yi-Tong Ma, Yang Li, Yang Li, Xian Wei, Dilare Adi, Yong-Tao Wang, Han Min, Fen Liu, Bang-Dang Chen, Xiao-Mei Li et al. · 2022 · PeerJ
Fibrate Pharmacogenomics: Expanding Past the Genome
John S. House, Alison A. Motsinger‐Reif · 2020 · Pharmacogenomics
Role of Rare and Low-Frequency Variants in Gene-Alcohol Interactions on Plasma Lipid Levels
Zhe Wang, Han Chen, Traci M. Bartz, Lawrence F. Bielak, Daniel I. Chasman, Mary Furlan Feitosa, Nora Franceschini, Xiuqing Guo, Elise Lim, Raymond Noordam et al. · 2020 · Circulation Genomic and Precision Medicine
Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9
Yuan Zhang, Ioannis Karakikes · 2020 · Trends in Cardiovascular Medicine
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction
Alberto Zambon, Angela Pirillo, Sabina Zambon, Giuseppe Danilo Norata, Alberico Luigi Catapano · 2020 · Current Atherosclerosis Reports
APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver Disease
Qing-Yang Xu, Han Li, Haixia Cao, Qin Pan, Jian‐Gao Fan · 2020 · BioMed Research International
Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants
Justine Cole, Diane Mary Blackhurst, Gabriele Anna Eva Solomon, Bharati D Ratanjee, Ryan L. Benjamin, Adrian David Marais · 2020 · Journal of clinical lipidology
Novel Mutations of Low-Density Lipoprotein Receptor Gene in China Patients with Familial Hypercholesterolemia
Liang‐Liang Fan, Minjie Lin, Yaqin Chen, Hao Huang, Daoquan Peng, Kun Xia, Shui‐Ping Zhao, Rong Xiang · 2015 · Applied Biochemistry and Biotechnology
EDEM3 Modulates Plasma Triglyceride Level Through Its Regulation of LRP1 Expression
Yuxin Xu, Gina Marie Peloso, Taylor Hanta Nagai, Taiji Mizoguchi, Amy Deik, Kevin H. Bullock, Honghuang Lin, Kiran Musunuru, Qiong Yang, Ramachandran Srini Vasan et al. · 2019 · iScience
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin
Marissa Lightbourne, Anna T Wolska, Brent S. Abel, Kristina I. Rother, Mary F. Walter, Yevgeniya S. Kushchayeva, Sungyoung Auh, Robert D. Shamburek, Alan Thomas Remaley, Ranganath Muniyappa et al. · 2020 · Journal of the Endocrine Society
Lipoprotein sialylation in atherosclerosis: Lessons from mice
Liming Yu, Jun Peng, Chieko Mineo · 2022 · Frontiers in Endocrinology
Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism
Satya Dash, Changting Xiao, Gary F. Lewis · 2015 · Current Opinion in Lipidology
Diabetes in Population Isolates: Lessons from Greenland
Niels Grarup, Ida Moltke, Anders Albrechtsen, Torben F. Hansen · 2015 · The Review of Diabetic Studies
Association of Exome Sequences With Cardiovascular Traits Among Blacks in the Jackson Heart Study
Gina Marie Peloso, Leslie A. Lange, Tibor V. Varga, Deborah A. Nickerson, Joshua D. Smith, Michael E Griswold, Solomon K. Musani, Linda M. Polfus, Hao Mei, Stacey Gabriel et al. · 2016 · Circulation Cardiovascular Genetics
LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?
Bernd Hewing, Ulf Landmesser · 2015 · Current Cardiology Reports
Research advances in current drugs targeting hyperlipidemia (Review)
Hanwei Zhao, Yao Wang, Yaqing Li, Ran Cheng, Wenge Chen · 2025 · Molecular Medicine Reports
The Emerging Potential of Apolipoprotein C-III Inhibition for ASCVD Prevention: A State-of-the-Art Review
Samuel David Maidman, Robert Alexander Hegele, Robert S. Rosenson · 2024 · Current Atherosclerosis Reports
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease
Megan Kalwick, Mendel M. Roth · 2025 · Nutrients
Risk reduction of ASCVD attributed to lowering of remnant cholesterol from statins, fibrates, APOC3 inhibitors, and ANGPTL3 inhibitors: a cohort study
Mie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, Anette Varbo, Martin Bødtker Mortensen, Anne Langsted, Børge Grønne Nordestgaard, Shoaib Afzal · 2025 · Atherosclerosis
Lipids and Lipoproteins in Risk Prediction
Savvas Hadjiphilippou, Kausik Kumar Ray · 2018 · Cardiology Clinics
Plasma Proteome Profiling of Patients With In-stent Restenosis by Tandem Mass Tag-Based Quantitative Proteomics Approach
Jingyuan Hou, Qiaoting Deng, Sudong Liu, Xiaohong Qiu, Xunwei Deng, Wei Hong Zhong, Zhixiong Zhong · 2022 · Frontiers in Cardiovascular Medicine
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling
Esther Reijnders, Arnoud van der Laarse, L. Renee Ruhaak, Christa M. Cobbaert · 2024 · Clinical Proteomics
Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: the Western Denmark Heart Registry
Malene Kærslund Hansen, Martin Bødtker Mortensen, Kevin Kris Warnakula Olesen, Pernille Gro Thrane, Reimar Wernich Thomsen, Michael Mæng · 2024 · European Journal of Preventive Cardiology
Human Adipose Cells In Vitro Are Either Refractory or Responsive to Insulin, Reflecting Host Metabolic State
Vladimir A. Lizunov, Karin G. Stenkula, Paul S. Blank, Aaron L. Troy, Jo-Ping Lee, Monica C. Skarulis, Samuel W. Cushman, Joshua J. Zimmerberg · 2015 · PLoS ONE
Treatment of Hyperlipidemia Changes With Level of Kidney Function—Rationale
Shubha Ananthakrishnan, George A. Kaysen · 2016 · Advances in Chronic Kidney Disease
Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias
Leopoldo Pérez de Isla, Leopoldo Pérez de Isla, Pedro Luis Sánchez Fernández, José Luis Álvarez-Sala, Vivencio Barrios Alonso, Almudena Castro Conde, Enrique Galve Basilio, Luis García‐Ortiz, Pedro Mata López, Eduardo Alegría Ezquerra et al. · 2017 · Revista Española de Cardiología (English Edition)
Dyslipidemia in Diabetes
Kenneth R. Feingold · 2020 · Europe PMC (PubMed Central)
Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia
Véronique Ferchaud‐Roucher, Yassine Zaïr, Audrey Aguesse, Michel Krempf, Khadija Ouguerram · 2020 · The Journal of Clinical Endocrinology & Metabolism
A Meta-Analysis on the Association Between TNFSF4 Polymorphisms (rs3861950 T > C and rs1234313 A > G) and Susceptibility to Coronary Artery Disease
Shuyan Liu, Xiju Wang, Shoujun Yu, Miao Yan, Yue Peng, Guilong Zhang, Zhaowei Xu · 2020 · Frontiers in Physiology
Apolipoprotein C-III
Michael J. Miller · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
How Genome Editing could be used in the Treatment of Cardiovascular Diseases
Kiran Musunuru · 2018 · Personalized Medicine
Cholesterol‐lowering drug targets reduce risk of dementia: Mendelian randomization and meta‐analyses of 1 million individuals
Liv Tybjærg Nordestgaard, Aimee Hanson, Eleanor C. M. Sanderson, Emma L. Anderson, Venexia M. Walker, Anne Tybjærg‐Hansen, George Davey Smith, Børge Grønne Nordestgaard · 2025 · Alzheimer s & Dementia
Effect of APOB polymorphism rs562338 (G/A) on serum proteome of coronary artery disease patients: a “proteogenomic” approach
Muneeza Zafar, Munazza Raza Mirza, Fazli Rabbi Awan, Muhammad Tahir, Rabia Sultan, Misbah Hussain, Bilal Ahmed, Shahid Abbas, Martin R. Larsen, Muhammad Iqbal Choudhary et al. · 2021 · Scientific Reports
A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy
Kyuho Kim, Sung Hee Choi · 2022 · Journal of Lipid and Atherosclerosis
Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults
Jinman Li, Honglin Sun, Ying Wang, Jia Liu, Guang Wang · 2023 · Lipids in Health and Disease
Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids
Annemieke Naber, Daniel Demus, Roderick C. Slieker, Simone Nicolardi, Joline W. J. Beulens, Petra J. M. Elders, Aloysius G. Lieverse, Eric J.G. Sijbrands, Leen M. ‘t Hart, Manfred Wuhrer et al. · 2023 · International Journal of Molecular Sciences
Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials
Lale S Tokgözoğlu, Angela Pirillo, Alberico Luigi Catapano · 2023 · European Heart Journal
Contemporary and Novel Therapeutic Options for Hypertriglyceridemia
Damon A. Bell, Gerald Francis Watts · 2015 · Clinical Therapeutics
Insights from population-based analyses of plasma lipids across the allele frequency spectrum
Peloso, Gina M, Natarajan, Pradeep · 2018 · Current Opinion in Genetics & Development
Apolipoprotein CIII may mediate the impacts of angiopoietin-like protein 8 on triglyceride metabolism
Mengdie Luo, Xin Su, Yuhong Yi, Yang Yang, Daoquan Peng · 2018 · Lipids in Health and Disease
Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease
Guanglin Cui, Min Tian, Senlin Hu, Yan Wang, Dao Wen Wang · 2020 · Journal of Molecular and Cellular Cardiology
Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes
Sabrina Prudente, Diego Bailetti, Christine Mendonça, Gaia Chiara Mannino, Andrea Fontana, Francesco Andreozzi, Timothy Hastings, Luana Mercuri, Federica Alberico, Giorgio Basile et al. · 2015 · Atherosclerosis
JCL roundtable: Apolipoproteins as causative elements in vascular disease
William Virgil Brown, Frank M. Sacks, Allan D. Sniderman · 2015 · Journal of clinical lipidology
Therapeutic inhibition of apoC-III for the treatment of hypertriglyceridemia
Thomas A Bell, Mark J. Graham, Brenda F. Baker, Rosanne M. Crooke · 2015 · Clinical Lipidology
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications
Hermann Toplak, Bernhard H. Ludvik, Monika Lechleitner, Hans Dieplinger, Bernhard Föger, Bernhard Paulweber, Thomas Weber, Bruno Watschinger, Sabine Horn, Thomas C. Wascher et al. · 2016 · Wiener klinische Wochenschrift
Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap
Klaus Georg Parhofer, M. John Chapman, Børge Grønne Nordestgaard · 2020 · European Heart Journal Supplements
Genetics of Coronary Atherosclerosis
Krishna G. Aragam, Sekar Kathiresan · 2017 · Elsevier eBooks